Key Points

  • High rates of bloodstream infections (BSI) were noted after fecal microbiota transplantation in patients with GvHD

  • A metagenomic analysis pointed to the recipients' indigenous microbiota as the BSI source, ruling out direct involvement of FMT donations

We observed high rates of bloodstream infections (BSIs) following fecal microbiota transplantation (FMT) for graft-versus-host-disease (33 events in 22 patients). To trace the BSIs' origin, we applied a metagenomic bioinformatic pipeline screening donor and recipient stool samples for bacteremia-causing strains in 13 cases. Offending strains were not detected in FMT donations. Enterococcus faecium, Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii could be detected in stool samples before emerging in the blood. In this largest report of BSIs post-FMT, we present an approach that may be applicable for evaluating BSI origin following microbiota-based interventions. Our findings support FMT safety in immunocompromised patients but do not rule out FMT as an inducer of bacterial translocation.

This content is only available as a PDF.

Article PDF first page preview

Article PDF first page preview

Supplemental data